Abstract
Determination of the magnitude of body iron stores helps to identify individuals at risk of iron-induced organ damage in Thalassemia patients. The most direct clinical method of measuring liver iron concentration (LIC) is through chemical analysis of needle biopsy specimens. Here we present a noninvasive method for the measurement of LIC in vivo using magnetic resonance imaging (MRI). Twenty-three pediatric Thalassemia major patients undergoing bone marrow transplantation at our centre were studied. All 23 patients had MRI T2* and R2* decay time for evaluation of LIC on a 1.5 Tesla MRI system followed by liver tissue biopsy for the assessment of iron concentration using an atomic absorption spectrometry. Simultaneously, serum ferritin levels were measured by enzymatic assay. We have correlated biopsy LIC with liver T2* and serum ferritin values with liver R2*. Of the 23 patients 11 were males, the mean age was 8.3 ± 3.7 years. The study results showed a significant correlation between biopsy LIC and liver T2* MRI (r = 0.768; p < 0.001). Also, there was a significant correlation between serum ferritin levels and liver R2* MRI (r = 0.5647; p < 0.01). Two patients had high variance in serum ferritin levels (2100 and 4100 mg/g) while their LIC was around 24 mg/g, whereas the difference was not seen in T2* MRI. Hence, the liver T2* MRI is a better modality for assessing LIC. Serum ferritin is less reliable than quantitative MRI. The liver T2* MRI is a safe, reliable, feasible and cost-effective method compared to liver tissue biopsy for LIC assessment.
Similar content being viewed by others
References
Brittenham GM, Badman DG, National Institute of Diabetes, and Digestive, and Kidney Diseases (, NIDDK, ) Workshop (2003) Noninvasive measurement of iron: report of an NIDDK workshop. Blood 101:15–19
Worwood M (1997) The laboratory assessment of iron status—an update. Clin Chim Acta Int J Clin Chem 259:3–23
Brittenham GM, Sheth S, Allen CJ, Farrell DE (2001) Noninvasive methods for quantitative assessment of transfusional iron overload in sickle cell disease. Semin Hematol 38:37–56
Lee MH, Means RT (1995) Extremely elevated serum ferritin levels in a university hospital: associated diseases and clinical significance. Am J Med 98:566–571
Olive A, Junca J (1996) Elevated serum ferritin levels: associated diseases and clinical significance. Am J Med 101:120
Villeneuve JP, Bilodeau M, Lepage R, Côté J, Lefebvre M (1996) Variability in hepatic iron concentration measurement from needle-biopsy specimens. J Hepatol 25:172–177
Emond MJ, Bronner MP, Carlson TH, Lin M, Labbe RF, Kowdley KV (1999) Quantitative study of the variability of hepatic iron concentrations. Clin Chem 45:340–346
Kreeftenberg HG, Koopman BJ, Huizenga JR, van Vilsteren T, Wolthers BG, Gips CH (1984) Measurement of iron in liver biopsies—a comparison of three analytical methods. Clin Chim Acta Int J Clin Chem 144:255–262
Koh TS, Benson TH, Judson GJ (1980) Trace element analysis of bovine liver: interlaboratory survey in Australia and New Zealand. J Assoc Off Anal Chem 63:809–813
Clark PR, Chua-anusorn W, St Pierre TG (2003) Bi-exponential proton transverse relaxation rate (R2) image analysis using RF field intensity-weighted spin density projection: potential for R2 measurement of iron-loaded liver. Magn Reson Imaging 21:519–530
Garbowski MW, Carpenter JP, Smith G, Roughton M, Alam MH, He T et al (2014) Biopsy-based calibration of T2* magnetic resonance for estimation of liver iron concentration and comparison with R2 Ferriscan. J Cardiovasc Magn Reson 16:40–51
Fischer R, Harmatz PR (2009) Non-invasive assessment of tissue iron overload. Hematol Am Soc Hematol Educ Program. https://doi.org/10.1182/asheducation-2009.1.215
Gianesin B, Zefiro D, Musso M, Rosa A, Bruzzone C, Balocco M et al (2012) Measurement of liver iron overload: noninvasive calibration of MRI-R2* by magnetic iron detector susceptometer. Magn Reson Med 67:1782–1786
Angulo IL, Covas DT, Carneiro AA, Baffa O, Elias Junior J, Vilela G (2008) Determination of iron-overload in thalassemia by hepatic MRI and ferritin. Rev Bras Hematol E Hemoter 30:449–452
Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH et al (2001) Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 22:2171–2179
Angelucci E, Baronciani D, Lucarelli G, Baldassarri M, Galimberti M, Giardini C et al (1995) Needle liver biopsy in thalassaemia: analyses of diagnostic accuracy and safety in 1184 consecutive biopsies. Br J Haematol 89:757–761
Barry M, Sherlock S (1971) Measurement of liver-iron concentration in needle-biopsy specimens. Lancet Lond Engl 1:100–103
Eghbali A, Taherahmadi H, Shahbazi M, Bagheri B, Ebrahimi L (2014) Association between serum ferritin level, cardiac and hepatic T2-star MRI in patients with major β-thalassemia. Iran J Pediatr Hematol Oncol 4:17–21
St Pierre TG, Clark PR, Chua-Anusorn W (2005) Measurement and mapping of liver iron concentrations using magnetic resonance imaging. Ann N Y Acad Sci 1054:379–385
Alexopoulou E, Stripeli F, Baras P, Seimenis I, Kattamis A, Ladis V et al (2006) R2 relaxometry with MRI for the quantification of tissue iron overload in beta-thalassemic patients. J Magn Reson Imaging 23:163–170
Hankins JS, McCarville MB, Loeffler RB, Smeltzer MP, Onciu M, Hoffer FA et al (2009) R2* magnetic resonance imaging of the liver in patients with iron overload. Blood 113:4853–4855
Brittenham GM, Cohen AR, McLaren CE, Martin MB, Griffith PM, Nienhuis AW et al (1993) Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia major. Am J Hematol 42:81–85
Nielsen P, Fischer R, Engelhardt R, Tondüry P, Gabbe EE, Janka GE (1995) Liver iron stores in patients with secondary haemosiderosis under iron chelation therapy with deferoxamine or deferiprone. Br J Haematol 91:827–833
Mandal S, Sodhi KS, Bansal D, Sinha A, Bhatia A, Trehan A et al (2017) MRI for quantification of liver and cardiac iron in Thalassemia Major patients: pilot study in Indian population. Indian J Pediatr 84:276–282
Majd Z, Haghpanah S, Ajami GH, Matin S, Namazi H, Bardestani M et al (2015) Serum ferritin levels correlation with heart and liver MRI and LIC in patients with transfusion-dependent Thalassemia. Iran Red Crescent Med J. 17:e24959
Akcay A, Salcioglu Z, Oztarhan K, Tugcu D, Aydogan G, Ayaz NA et al (2014) Cardiac T2* MRI assessment in patients with thalassaemia major and its effect on the preference of chelation therapy. Int J Hematol 99:706–713
Kliewer MA, Sheafor DH, Paulson EK, Helsper RS, Hertzberg BS, Nelson RC (1999) Percutaneous liver biopsy: a cost-benefit analysis comparing sonographic and CT guidance. AJR Am J Roentgenol 173:1199–1202
Gilmore IT, Burroughs A, Murray-Lyon IM, Williams R, Jenkins D, Hopkins A (1995) Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. Gut 36:437–441
Funding
This research did not receive any specific grant from government of private funding agencies.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bafna, V., Bhat, S., Raj, V. et al. Quantification of Liver Iron Overload: Correlation of MRI and Liver Tissue Biopsy in Pediatric Thalassemia Major Patients Undergoing Bone Marrow Transplant. Indian J Hematol Blood Transfus 36, 667–673 (2020). https://doi.org/10.1007/s12288-020-01256-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-020-01256-1